Stockholm-Based Loovi Raises €1M To Expand Preventive Health And Longevity Platform

Investors include Susanne Najafi (BackingMinds), Sïmon Saneback (Wellstreet), Jarno Hottinen (Otmore), Emad Zand (Northvolt), Benoit Falenius (Markify), Ultan Miller, and Charles Morel.

“The challenge today is not a lack of data, but that people are often left alone with numbers that are difficult to interpret and prioritise. At the same time, longevity has become associated with extreme routines that few can realistically maintain. Our ambition is to make proactive health management more relatable, understandable, and sustainable over time,” says Joel Grajcer, Co-founder and CEO of Loovi .

Alongside Loovi’s €1 million raise, EU-Startups has highlighted several comparable preventive HealthTech funding rounds across Europe in 2025 and early 2026.

In Switzerland, Ahead Health secured €5.1 million to scale its preventive healthcare platform and expand clinic partnerships, while Zurich-based Aeon raised €8.2 million for its AI-powered preventive health and risk profiling platform. In France, Lucis closed €7.2 million to advance AI-driven biomarker interpretation and preventive health checks. Barcelona-based Holo in Spain raised €1 million to expand personalized lab testing and wearable data integration, and Polish-American startup Mos Health secured roughly €920k to develop its AI-powered preventive health solution.

Read Also - Electric Twin Raises $14M Funding To Grow Its AI Audience Platform

Combined, these rounds total over €21 million, reflecting strong investor interest in early detection, biomarker analysis, wearable data integration, and structured preventive care.

While no other Swedish preventive HealthTech rounds were reported in this sample, Loovi is part of a broader, geographically dispersed European trend toward data-driven, proactive healthcare models.

“We want to shift the focus from reacting to diagnoses to acting on early signals. There are more health services available than ever before, but few that take the full health picture into account. Our ambition has been to bring together multiple sources of health data, interpret them in a medical context, and guide users over time, not only through technology, but also through human interaction and educational support,” adds Kevin Najafi, MD and co-founder of Loovi.

Founded in 2025 by Joel Grajcer and Dr. Kevin Najafi, Loovi offers Europe’s first end-to-end digital platform for longevity and preventive health. The platform integrates medical analysis, physical testing, wearable data, and personalized guidance, helping individuals proactively understand and manage their health over time.

Loovi’s mission is to shift healthcare from reactive treatment to structured, data-driven prevention. Today, many lifestyle-related conditions are detected too late, and follow-up or behavioral support is limited. Simultaneously, large volumes of health data from tests, clinical visits, and wearables are fragmented and hard to turn into actionable insights.

Loovi consolidates blood markers, test results, lifestyle data, and physical assessments into a single platform. By analyzing multiple data sources together, it creates a comprehensive health overview, forming the basis for personalized recommendations. An AI-powered intelligence layer helps users understand how different factors interact and influence health over time.

Designed as an ongoing program, not a one-off check-up, Loovi emphasizes continuity, realistic lifestyle adjustments, and sustainable habits. The recent funding will be used to enhance the platform, expand medical and technical capabilities, and support a wider European rollout.

About Loovi

Loovi is Europe’s first end-to-end digital longevity platform, empowering you to own your health. Combining medical testing, tracking and data-driven insights with guidance from doctors, personal trainers, and wellness experts, Loovi helps you take proactive, science-backed steps to improve health, prevent disease, and maintain well-being throughout life.